Stocks and Investing
Stocks and Investing
Wed, December 14, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 13, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Samantha Semenkow Initiated (SNSE) at Strong Buy and Held Target at $6 on, Dec 13th, 2022
Samantha Semenkow of Citigroup, Initiated "Sensei Biotherapeutics, Inc." (SNSE) at Strong Buy and Held Target at $6 on, Dec 13th, 2022.
Samantha has made no other calls on SNSE in the last 4 months.
There is 1 other peer that has a rating on SNSE. Out of the 1 peers that are also analyzing SNSE, 0 agree with Samantha's Rating of Hold.
This is the rating of the analyst that currently disagrees with Samantha
- Francois Brisebois of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $5 on, Monday, October 3rd, 2022
Contributing Sources